Four Innovative Neurostimulation Devices by PINS Medical Receive NMPA Approval

May 29, 2024 18:45 CST Updated 18:45

Pins

Neuromodulation Product R&D, Production, and Sales

Source:SiYu MedTech

On May 28, 2024, NMPA approvedBeijing Pins Medical Co., Ltd.Implantable Deep Brain Stimulation Electrode Lead Kit, Dual-Channel Rechargeable Implantable Deep Brain Stimulation Pulse Generator Kit, Dual-Channel Implantable Deep Brain Stimulation Pulse Generator KitAndImplantable Deep Brain Stimulation Extension Lead KitRegistration applications for four innovative products.

Original Text:

"The above product isThe First Directional in ChinaDeep Brain Stimulation Products, when used in conjunction, can stimulate the subthalamic nucleus or globus pallidus internus, and is used for cases where medications cannot effectively control certain symptoms.Advanced L-DOPA Responsive Parkinson's DiseasePatients undergo combination therapy. Compared with traditional electrodes, the aforementioned products can provide directional stimulation to specific functional subregions of the target nucleus.At the same time, in the case of slight electrode misplacement, it can avoid the side effects of deep brain stimulation and reduce the risk of reoperation for electrode implantation.。”

About Deep Brain Stimulation

"Brain Pacemaker" implantation, commonly known as Deep Brain Stimulation (DBS).

DBS involves the use of a pulse generator to stimulate certain nuclei deep in the brain, correcting abnormal brain electrical circuits to achieve therapeutic or improvement effects. As an intervention method that uses electrical energy to influence brain neural activity, it is currently the most widely accepted and important treatment. Related research is also exploring the use of DBS to treat other brain-related diseases, such as severe depression and Alzheimer's disease.

In 1998, Deep Brain Stimulation (DBS) therapy entered China;

In 1999, DBS was registered in China for the treatment of Parkinson's disease and essential tremor;

In 2016, China approved DBS for the treatment of dystonia and refractory epilepsy.

▲History of DBS Development

After the traditional DBS electrode is implanted in the human brain, it sends omnidirectional electrical pulses to the target in the brain through the electrode contacts for stimulation. While improving the patient's motor symptoms, a higher level of stimulation can sometimes bring about some side effects.

About a decade ago, the DBS market witnessed the entry of several emerging companies, namely St. Jude Medical (later acquired by Abbott), Boston Scientific, SceneRay, PINS, Neuropace, and Aleva Neurotherapeutics. Their arrival brought significant technological innovations to the market, including the application of segmented leads, improved precision in directional stimulation, significantly extended battery life, enhanced flexibility in setting stimulation parameters, and internet-based remote programming. These innovative technologies injected new vitality into the development of the DBS market.

Recent developments include current directionality and electrode segmentation, expanded programming parameter space (particularly shorter pulse widths (10 microseconds) and frequencies up to 10,000 Hz), as well as advancements in MRI compatibility and neural recording capabilities.

Directional Deep Brain Stimulation System——An advanced system based on traditional DBS therapy, utilizing electrodes with more stimulation contacts (directional) and specific stimulation programs. It aims to identify more precise stimulation methods, reduce side effects caused by stimulation, and conserve energy consumption.

As of the date of publication, other approved deep brain stimulators and related accessories are as follows:

About Pins Medical

Beijing Pins Medical Co., Ltd. (hereinafter referred to as "Pins Medical") was founded in 2008, with its headquarters located in the Changping Park of Zhongguancun Science and Technology Park, Beijing. Pins Medical is a high-tech enterprise specializing in the research, production, and sales of a series of neuromodulation products, including brain pacemakers, vagus nerve stimulators, spinal cord stimulators, and sacral nerve stimulators. It is committed to providing advanced treatment options for patients with functional neurological disorders such as Parkinson's disease, epilepsy, pain, and urinary incontinence.

In 2023,Pins Medical Recognized as a National Enterprise Technology Center: Total Implantations Across Full Product Line Exceed 30,000 Cases, Covering Nearly 600 Hospitals Across China

Pins Medical's Neuromodulation System (Brain Pacemaker) began its research and development in 2000, successfully conducted the first clinical trial in 2009, obtained product registration certificates for the full series of brain pacemakers in 2014, and received CE certification in October 2016. By the end of 2023, Pins has over 450+ clinical cooperation centers in China, with more than 25,000 patients implanted nationwide.

Through collaboration with numerous clinical hospitals such as Tsinghua University, Beijing Tiantan Hospital, and Peking Union Medical College Hospital,Pins MedicalEstablished a "Production-Academia-Research-Medicine" collaborative innovation model. The series of brain pacemakers have been under development by Professor Li Luoming's team from Tsinghua University since 2000, with the first clinical trial conducted in 2009. The full series of DBS products obtained registration certificates in 2014 and received CE certification in 2016.

Pins® 3.0T MRI-Compatible Brain Stimulator (G106/G106R Model), jointly developed by Pins Medical and Tsinghua University, is a product with full independent intellectual property rights. It addresses the world-class medical safety issue of heat generation in DBS electrode leads implanted in patients during MRI scans, which can cause thermal damage to surrounding tissues, through innovative anti-interference design.

Pins® 3.0T MRI-Compatible Brain Stimulator (G106/G106R Type)In February 2019, it was selected for the special review process of the National Innovative Medical Device Program, and in January 2022, it received approval from the National Medical Products Administration.Class III Medical DevicesRegistration Certificate, selected for the National "13th Five-Year Plan" Science and Technology Innovation Achievement Exhibition, and included in "China's Important Medical Advances of 2022".

Pins® 3.0T MRI-Compatible Bluetooth Sensing Brain Stimulator (G106RS Model)Approved for marketing with the Class III Medical Device Registration Certificate obtained in March 2023,China's First MRI-Compatible Bluetooth-Enabled Brain Pacemaker, Filling the Domestic Gap。

▲ Pins Medical 3.0T MRI-Compatible Brain Pacemaker

On July 4, 2023, the new generation "Bluetooth-detectable, rechargeable, and remotely programmable 3.0T MRI-compatible brain pacemaker (Model 106RS)" completed its first clinical application post-market at the First Affiliated Hospital of USTC (Anhui Provincial Hospital), marking another advancement in China's neuromodulation field.

As of the date of this report, the company's financing history is as follows:

As of the date of this report, the following partial patent information of the company has been queried:

This article is a repost and is intended for sharing only. The views expressed in the article are those of the original platform's author and are not related to this platform.If this article overlaps with original content published on your platform or is used without authorization, it is the action of the original platform, and this platform only reproduces it.You can contact us to delete the article at the first time (WeChat:lqsgogogo), we will respond immediately!

*WideNotice

MRI, CT, Imaging, IVD, Hospital Information System......

Latest Research Report

#2023 MRI Report in China

#2023 China CT Report

# China Health Statistics Yearbook 2022

# Survey on the Information Status of Chinese Hospitals 2021-2022

#Medical Ultrasound #Endoscope #Monitoring #Cardiac Electrophysiology #Rehabilitation #Reproductive Health #Dental #Medical Aesthetics #Home Medical Device Field Report......

Click to follow "Medical Device Distributors Alliance"

Reply to the keyword "8888”, can be claimed

Advertising, Business Cooperation: Manager Jin 13072506726

I love every like and view from you!